Casanova Víctor, Rodríguez-Agustín Andrea, Ayala-Suárez Rubén, Moraga Elisa, Maleno María José, Mallolas Josep, Martínez Esteban, Sánchez-Palomino Sonsoles, Miró José M, Alcamí José, Climent Núria
AIDS and HIV Infection Group, Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain.
Department of Medicine, Universitat de Barcelona (UB), Barcelona, Spain.
Front Immunol. 2025 Apr 24;16:1568762. doi: 10.3389/fimmu.2025.1568762. eCollection 2025.
Current antiretroviral therapy (ART) for HIV infection reduces plasma viral loads to undetectable levels and has increased the life expectancy of people with HIV (PWH). However, this increased lifespan is accompanied by signs of accelerated aging and a higher prevalence of age-related comorbidities. Tat (Trans-Activator of Transcription) is a key protein for viral replication and pathogenesis. Tat is encoded by 2 exons, with the full-length Tat ranging from 86 to 101 aa (Tat). Introducing a stop codon in position 73 generates a 1 exon, synthetic 72aa Tat (Tat). Intracellular, full-length Tat activates the NF-κB pro-inflammatory pathway and increases antiapoptotic signals and ROS generation. These effects may initiate a cellular senescence program, characterized by cell cycle arrest, altered cell metabolism, and increased senescence-associated secretory phenotype (SASP) mediator release However, the precise role of HIV-Tat in inducing a cellular senescence program in CD4 T-cells is currently unknown.
Jurkat Tet cell lines stably transfected with Tat, Tat, or an empty vector were used. Flow cytometry and RT-qPCR were used to address senescence biomarkers, and 105 mediators were assessed in cell supernatants with an antibody-based membrane array. Key results obtained in Jurkat-Tat cells were addressed in primary, resting CD4 T-cells by transient electroporation of HIV-Tat-FLAG plasmid DNA.
In the Jurkat cell model, expression of Tat increased the levels of the senescence biomarkers BCL-2, CD87, and p21, and increased the release of sCD30, PDGF-AA, and sCD31, among other factors. Tat upregulated CD30 and CD31 co-expression in the Jurkat cell surface, distinguishing these cells from Tat and Tet Jurkats. The percentage of p21, p16, and γ-H2AX cells were higher in Tat-expressing CD4 T-cells, detected as a FLAG population compared to their FLAG (Tat negative) counterparts. Increased levels of sCD31 and sCD26 were also detected in electroporated CD4 T-cell supernatants.
Intracellular, full-length HIV-Tat expression increases several senescence biomarkers in Jurkat and CD4 T-cells, and SASP/Aging mediators in cell supernatants. Intracellular HIV-Tat may initiate a cellular senescence program, contributing to the premature aging phenotype observed in PWH.
目前用于治疗HIV感染的抗逆转录病毒疗法(ART)可将血浆病毒载量降低至检测不到的水平,并延长了HIV感染者(PWH)的预期寿命。然而,这种寿命的延长伴随着加速衰老的迹象以及与年龄相关的合并症的更高患病率。Tat(转录反式激活因子)是病毒复制和发病机制的关键蛋白。Tat由2个外显子编码,全长Tat范围为86至101个氨基酸(Tat)。在第73位引入终止密码子可产生1个外显子的、合成的72个氨基酸的Tat(Tat)。在细胞内,全长Tat激活NF-κB促炎途径,并增加抗凋亡信号和活性氧的产生。这些作用可能启动细胞衰老程序,其特征为细胞周期停滞、细胞代谢改变以及衰老相关分泌表型(SASP)介质释放增加。然而,HIV-Tat在诱导CD4 T细胞中的细胞衰老程序中的确切作用目前尚不清楚。
使用稳定转染了Tat、Tat或空载体的Jurkat Tet细胞系。采用流式细胞术和RT-qPCR检测衰老生物标志物,并使用基于抗体的膜阵列评估细胞上清液中的105种介质。通过瞬时电穿孔HIV-Tat-FLAG质粒DNA,在原代静息CD4 T细胞中研究在Jurkat-Tat细胞中获得的关键结果。
在Jurkat细胞模型中,Tat的表达增加了衰老生物标志物BCL-2、CD87和p21的水平,并增加了sCD30、血小板衍生生长因子AA(PDGF-AA)和sCD31等因子的释放。Tat上调了Jurkat细胞表面CD30和CD31的共表达,从而将这些细胞与Tat和Tet Jurkats细胞区分开来。与表达FLAG(Tat阴性)的对应细胞相比,在表达Tat的CD4 T细胞中,检测为FLAG群体的p21、p16和γ-H2AX细胞的百分比更高。在电穿孔的CD4 T细胞上清液中也检测到sCD31和sCD26水平升高。
在细胞内,全长HIV-Tat的表达增加了Jurkat细胞和CD4 T细胞中的几种衰老生物标志物,以及细胞上清液中的SASP/衰老介质。细胞内的HIV-Tat可能启动细胞衰老程序,导致在PWH中观察到的早衰表型。